{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:26:43Z","timestamp":1790479603986,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jep.2025.119748","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T13:03:47Z","timestamp":1743944627000},"page":"119748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Tripterygium glycoside tablets and triptolide alleviate experimental autoimmune encephalomyelitis mice involving the PACAP\/cAMP signaling pathway"],"prefix":"10.1016","volume":"347","author":[{"given":"Hong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4202-9607","authenticated-orcid":false,"given":"Jingwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4073-4773","authenticated-orcid":false,"given":"Fujiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jep.2025.119748_bib1","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s10072-021-05682-5","article-title":"Significance of serum VIP and PACAP in multiple sclerosis: an exploratory case-control study","volume":"43","author":"Al-Keilani","year":"2022","journal-title":"Neurol. Sci."},{"issue":"10","key":"10.1016\/j.jep.2025.119748_bib2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","article-title":"Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues","volume":"19","author":"Benedict","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jep.2025.119748_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.biopha.2017.07.073","article-title":"Toxicity of triptolide and the molecular mechanisms involved","volume":"90","author":"Chen","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.jep.2025.119748_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/biom10010137","article-title":"Microglia mediated neuroinflammation: focus on PI3K modulation","volume":"10","author":"Cianciulli","year":"2020","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.jep.2025.119748_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41582-020-00448-7","article-title":"Standardization and digitization of clinical data in multiple sclerosi s","volume":"17","author":"D'Souza","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"9","key":"10.1016\/j.jep.2025.119748_bib6","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/iub.2099","article-title":"The modulatory effects of luteolin on cyclic AMP\/ciliary neurotrophic factor signaling pathway in experimentally induced autoimmune encephal omyelitis","volume":"71","author":"El-Deeb","year":"2019","journal-title":"IUBMB Life"},{"issue":"12","key":"10.1016\/j.jep.2025.119748_bib7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41573-019-0035-2","article-title":"Progressive multiple sclerosis: from pathophysiology to therapeutic st rategies","volume":"18","author":"Faissner","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"15","key":"10.1016\/j.jep.2025.119748_bib8","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.7150\/thno.57745","article-title":"Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives","volume":"11","author":"Gao","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jep.2025.119748_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154813","article-title":"Toxic effects of tripterygium glycoside tablets on the reproductive system of Male rats by metabolomics, cytotoxicity, and molecular docking","volume":"114","author":"Ge","year":"2023","journal-title":"Phytomedicine"},{"issue":"8","key":"10.1016\/j.jep.2025.119748_bib10","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1073\/pnas.92.8.3601","article-title":"Prevention of autoimmune demyelination in non-human Primates by a cAMP -specific phosphodiesterase inhibitor","volume":"92","author":"Genain","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jep.2025.119748_bib11","first-page":"197","article-title":"Study on the content of the main active ingredients of Tripterygium wilfordii glycosides","volume":"33","author":"He","year":"2013","journal-title":"Journal of Drug Analysis"},{"issue":"1","key":"10.1016\/j.jep.2025.119748_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s10194-018-0855-1","article-title":"Discovery of PACAP and its receptors in the brain","volume":"19","author":"Hirabayashi","year":"2018","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.jep.2025.119748_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154972","article-title":"DCTPP1, a reliable Q-biomarker for comprehensive evaluation of the quality of tripterygium glycoside tablets based on chemical references","volume":"119","author":"Huang","year":"2023","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.jep.2025.119748_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.31083\/j.jin2101033","article-title":"Targeting the neurological comorbidities of multiple sclerosis: the beneficial effects of VIP and PACAP neuropeptides","volume":"21","author":"Jansen","year":"2022","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.jep.2025.119748_bib15","first-page":"5338","article-title":"Simultaneous determination of seven quality control components in Tripterygium wilfordii and its preparation Tripterygium wilfordii polyglycosides tablets by one-test-multiple-evaluation method","volume":"53","author":"Ji","year":"2022","journal-title":"Chinese Herbal Medicine"},{"issue":"6","key":"10.1016\/j.jep.2025.119748_bib16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1191\/1352458504ms1096oa","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the function s of antigen presenting cells","volume":"10","author":"Kato","year":"2004","journal-title":"Mult. Scler."},{"issue":"11","key":"10.1016\/j.jep.2025.119748_bib17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41582-021-00556-y","article-title":"Apparent changes in the epidemiology and severity of multiple sclerosis","volume":"17","author":"Koch-Henriksen","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jep.2025.119748_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fnmol.2016.00084","article-title":"NF-\u03baB pathways in the pathogenesis of multiple sclerosis and the therapeutic implications","volume":"9","author":"Leibowitz","year":"2016","journal-title":"Front. Mol. Neurosci."},{"issue":"7","key":"10.1016\/j.jep.2025.119748_bib19","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.4049\/jimmunol.1000986","article-title":"Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population","volume":"185","author":"Li","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jep.2025.119748_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.608703","article-title":"Clinical practice guideline for tripterygium glycosides\/tripterygium wilfordii tablets in the treatment of rheumatoid arthritis","volume":"11","author":"Lin","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jep.2025.119748_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.lfs.2017.05.010","article-title":"Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K\/Akt signaling pathway","volume":"180","author":"Liu","year":"2017","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.jep.2025.119748_bib22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.jep.2025.119748_bib23","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1111\/bph.13192","article-title":"PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis","volume":"172","author":"Mestre","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"29","key":"10.1016\/j.jep.2025.119748_bib24","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.2174\/138161212802502224","article-title":"The ambivalent role of apoptosis in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"18","author":"Reichardt","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jep.2025.119748_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109647","article-title":"Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: involvement of the PI3K\/Akt\/GSK-3\u03b2 pathway","volume":"115","author":"Sadek","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jep.2025.119748_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2022.12.020","article-title":"Selective PDE4 subtype inhibition provides new opportunities to interv ene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis","volume":"109","author":"Schepers","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jep.2025.119748_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176929","article-title":"Vortioxetine ameliorates experimental autoimmune encephalomyelitis mod el of multiple sclerosis in mice via activation of PI3K\/Akt\/CREB\/BDNF Cascade and modulation of serotonergic pathway signaling","volume":"982","author":"Shafiek","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.jep.2025.119748_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061200","article-title":"Pituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAE","volume":"8","author":"Tan","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jep.2025.119748_bib29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1474-4422(21)00170-8","article-title":"Multiple sclerosis under the spotlight","volume":"20","year":"2021","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jep.2025.119748_bib30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1039\/D0NP00054J","article-title":"Triptolide: reflections on two decades of research and prospects for the future","volume":"38","author":"Tong","year":"2021","journal-title":"Nat. Prod. Rep."},{"issue":"1","key":"10.1016\/j.jep.2025.119748_bib31","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12974-022-02676-8","article-title":"Inhibition of CCR2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the PI3K\/Akt pathway","volume":"19","author":"Tian","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.jep.2025.119748_bib32","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/ar.22479","article-title":"Effect of triptolide on T-cell receptor beta variable gene mRNA expression in rats with collagen-induced arthritis","volume":"295","author":"Wang","year":"2012","journal-title":"Anat. Rec."},{"key":"10.1016\/j.jep.2025.119748_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1269862","article-title":"Ursolic acid derivative UAOS-Na treats experimental autoimmune encepha lomyelitis by immunoregulation and protecting myelin","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Neurol."},{"issue":"7","key":"10.1016\/j.jep.2025.119748_bib34","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1089\/acm.2016.0004","article-title":"The pharmacological effects and mechanism of Tripterygium wilfordii hook F in central nervous system autoimmunity","volume":"22","author":"Wang","year":"2016","journal-title":"J. Alternative Compl. Med."},{"issue":"16","key":"10.1016\/j.jep.2025.119748_bib35","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.3390\/molecules27165102","article-title":"Comprehensive evaluation of the quality of tripterygium glycosides tablets based on multi-component quantification combined with an in vitro biological assay","volume":"27","author":"Wang","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jep.2025.119748_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11655-012-1236-2","volume":"20","author":"Wang","year":"2014","journal-title":"Chin. J. Integr. Med."},{"issue":"22","key":"10.1016\/j.jep.2025.119748_bib37","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.3390\/cells12222633","article-title":"Potential crosstalk between the PACAP\/VIP neuropeptide system and endoplasmic reticulum stress-relevance to multiple sclerosis pathophysiology","volume":"12","author":"Withana","year":"2023","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.jep.2025.119748_bib38","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2174\/187152708787122941","article-title":"NF-kappa B, a potential therapeutic target for the treatment of multiple sclerosis","volume":"7","author":"Yan","year":"2008","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"issue":"15","key":"10.1016\/j.jep.2025.119748_bib39","article-title":"Effectiveness and safety of Tripterygium wilfordii poly-glycosides on glomerulonephritis: a systematic review and meta-analysis","volume":"22","author":"Yan","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jep.2025.119748_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.intimp.2018.11.036","article-title":"Natural products: potential therapeutic agents in multiple sclerosis","volume":"67","author":"Yu","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.jep.2025.119748_bib41","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/med.21762","article-title":"Tripterygium wilfordii: an inspiring resource for rheumatoid arthritis treatment","volume":"41","author":"Zhang","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jep.2025.119748_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.intimp.2019.02.047","article-title":"Triptolide ameliorates lupus via the induction of miR-125a-5p mediating treg upregulation","volume":"71","author":"Zhao","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.jep.2025.119748_bib43","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1080\/21655979.2022.2052671","article-title":"Protecting effect of emodin in experimental autoimmune encephalomyelitis mice by inhibiting microglia activation and inflammation via Myd88\/PI3K\/Akt\/NF-\u03baB signalling pathway","volume":"13","author":"Zheng","year":"2022","journal-title":"Bioengineered"},{"issue":"2","key":"10.1016\/j.jep.2025.119748_bib44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/cns.12039","article-title":"Triptolide with potential medicinal value for diseases of the central nervous system","volume":"19","author":"Zheng","year":"2013","journal-title":"CNS Neurosci. Ther."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874125004325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874125004325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:06:22Z","timestamp":1779807982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874125004325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":44,"alternative-id":["S0378874125004325"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2025.119748","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tripterygium glycoside tablets and triptolide alleviate experimental autoimmune encephalomyelitis mice involving the PACAP\/cAMP signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2025.119748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119748"}}